Scientific Publications
Integrative Oncology Research | Clinical Case Reports | Scientific Commentary
Dr. Walter Lemmo’s published work reflects his longstanding interest in integrative oncology, cancer treatment interactions, investigational therapeutic approaches and evidence-informed clinical practice.
His scholarly contributions include peer-reviewed journal publications, clinical case reports, professional articles and scientific commentary.
Recent Publications & Commentary — 2026
Micronized Progesterone in Advanced Endometrial Cancer: Two Integrative Naturopathic Oncology Case Reports
Walter Lemmo, ND, FABNO
Naturopathic Doctor News & Review (NDNR) — September 2026
This article presents two clinical cases involving advanced or recurrent high-risk endometrial cancer in which micronized progesterone was incorporated primarily for sleep and quality-of-life support alongside broader oncology care.
The cases explore questions concerning hormonal mechanisms, supportive care and potential directions for further research. As observational reports involving multiple therapies, they do not establish an independent anticancer effect of micronized progesterone.
Critical Issues With Recent CAM Survival Cohort Study
Dugald Seely, Paul S. Anderson, Ian D. Bier, Walter Lemmo and Davis Lamson
JAMA Network Open — Online Scholarly Commentary, March 25, 2026
This co-authored commentary responds to research examining complementary and alternative medicine use among patients with breast cancer.
The authors discuss methodological concerns involving identification of complementary medicine users, potential exposure misclassification and interpretation of observational survival findings.
The commentary highlights the importance of accurate research methodology when evaluating integrative oncology.
Peer-Reviewed Research & Clinical Case Reports
Anti-Estrogen Withdrawal Effect With Raloxifene? A Case Report
Walter Lemmo
Integrative Cancer Therapies. 2016;15(3):245–249.
DOI: 10.1177/1534735416658954
This case report describes clinical observations following raloxifene withdrawal in a patient with metastatic hormone-receptor-positive breast cancer.
The report discusses possible hormonal withdrawal mechanisms and their relevance to further investigation.
Prolonged Survival After Dichloroacetate Treatment of Non-Small-Cell Lung Carcinoma-Related Leptomeningeal Carcinomatosis
Walter Lemmo and Gerard Tan
Journal of Medical Cases. 2016;7(4):136–142.
DOI: 10.14740/jmc2456w
This observational case report describes the clinical course of a patient with non-small-cell lung cancer complicated by leptomeningeal carcinomatosis who received investigational dichloroacetate.
The report discusses prolonged survival and possible research implications. A single case cannot establish the efficacy or safety of dichloroacetate as an anticancer treatment.
Potential Interactions of Prescription and Over-the-Counter Medications Having Antioxidant Capabilities With Radiation and Chemotherapy
Walter Lemmo
International Journal of Cancer. 2015;137(11):2525–2533.
DOI: 10.1002/ijc.29208
This review examines potential interactions between the antioxidant properties of commonly used prescription and nonprescription medications and conventional cancer treatments.
It explores considerations relevant to pharmacological interactions, radiation therapy and chemotherapy.
Research and Professional Collaboration
Dr. Walter Lemmo, NMD, FABNO, serves as Director of Clinical Research at Sunridge Medical in Scottsdale, Arizona.
Through LEMMO Oncology, his professional interests include advancing scientific discussion, evaluating emerging evidence and exploring opportunities for interdisciplinary collaboration in integrative oncology.
Learn more about Dr. Lemmo at Sunridge Medical
Research information: Publications and clinical case reports are presented for scientific and educational purposes. Observational findings should be interpreted according to their methodological limitations and should not be taken as proof of treatment effectiveness.